Multiple Sclerosis News Today is providing comprehensive and in-depth coverage of the eighth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023 in San Diego, California. The theme of this year’s conference is “MS: Going Viral.”
GA Depot, an experimental long-acting version of glatiramer acetate, significantly reduced relapse rates and prevented the development of new lesions among people with relapsing forms of multiple sclerosis, according to new data from a Phase 3 clinical…
New data from a Phase 2 clinical trial testing vidofludimus calcium, Immunic Therapeutics’ novel oral treatment candidate for relapsing-remitting multiple sclerosis (RRMS), show promising safety and efficacy, according to the company’s chief medical officer. The therapy was…
Can Do MS has three missions for people with multiple sclerosis (MS) and their care partners — providing education about life with the disease, building connections among people, and activating them to be proactive about managing their…
People with multiple sclerosis (MS) being treated with Ocrevus (ocrelizumab) less frequently than the recommended every six months are not more likely to experience inflammatory disease activity, an analysis of some 360 patients whose dosing schedules changed…
Even the cold and rainy Southern California weather did little to dampen the excitement of the more than 1,800 attendees converging on the Marriott Marquis San Diego Marina. People filtered in, eager for the meeting to begin. Excitement reached…
Briumvi (ublituximab-xiiy) recently became the third anti-CD20 monoclonal antibody to be approved by the U.S. Food and Drug Administration (FDA) as a treatment for relapsing forms of multiple sclerosis (MS). TG Therapeutics, the therapy’s developer, is…
Treatment with the experimental oral therapy ibudilast (MN-166) does not significantly improve quality-of-life measures compared with a placebo among people with progressive forms of multiple sclerosis (MS), according to new data from a Phase 2 clinical trial.
Taking high-dose vitamin D supplements as an add-on to standard MS treatment doesn’t reduce the risk of inflammatory disease activity for people with relapsing-remitting multiple sclerosis (RRMS), according to data from a clinical trial. The findings…
Certain cells in the eyes — specifically blood vessel cells and a type of neurological immune cell called microglia — exhibit high expression or activity of genes that have been linked to multiple sclerosis…
Multiple sclerosis (MS) has long been considered a disease that mostly affects white women. But in the U.S., the numbers indicate that Black people, particularly Black women, may be more likely to develop the neurodegenerative disease than people…
Senior science writer Marisa Horak, MS, and science writer Lindsey Shapiro, PhD, talk about how they came to Bionews and Multiple Sclerosis News Today, why conferences like ACTRIMS are important, and the highlights of this year’s forum.
Mitzi Joi Williams, MD, founding medical director of Joi Life Wellness, talks about the documentary “MS in Black and African Americans,” progress that has been made in addressing racial disparities in MS care and research, and what still needs to be done to close the gap.
MS advocate and patient Tyler Campbell discusses the documentary “MS in Black and African Americans,” his MS diagnosis journey, and the importance of taking action to address health inequities among the Black MS community.
Michael Hotchkin, chief development officer of Clene Nanomedicine, explains how experimental therapy CNM-Au8 may help MS patients see improvements in their everyday lives. Full story to come.
Michael Weiss, CEO of TG Therapeutics, talks to Multiple Sclerosis News Today about the pricing of newly approved MS therapy Briumvi (ublituximab) and how they are helping people with MS afford the treatment.
Multiple Sclerosis News Today talks to Mitzi Joi Williams, MD, MS specialist and founding medical director of Joi Life Wellness, about health inequity in Black people with MS and what further work needs to be done to close the gap. Full story and video to come.
MS patient and advocate Tyler Campbell sits down with Multiple Sclerosis News Today to talk about his MS experience and the documentary “MS in Black and African Americans,” which premiered Thursday night at ACTRIMS. Full story and video to come.
Can Do MS Chief Operating Officer Kathy Costello chats with Multiple Sclerosis News Today about the upcoming programs and initiatives they’re most excited about. Full story to come.
Get regular updates to your inbox.
